Comparison of Measurement Techniques and Response Criteria for MR Imaging Follow-up in Adult Primary Central Nervous System Lymphoma

References

1. 1.↵
   2. Miller AB,
   3. Hoogstraten B,
   4. Staquet M, et al

   . Reporting results of cancer treatment. Cancer 1981;47:207–14 doi:10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6 pmid:7459811

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Küker W,
   3. Nägele T,
   4. Thiel E, et al

   . Primary central nervous system lymphomas (PCNSL): MRI response criteria revised. Neurology 2005;65:1129–31 doi:10.1212/01.wnl.0000178894.51436.54 pmid:16217075

   Abstract/FREE Full Text
3. 3.↵
   2. Lin NU,
   3. Lee EQ,
   4. Aoyama H, et al

   . Response Assessment in Neuro-Oncology (RANO) group. Response assessment criteria for brain metastases: proposal from the RANO group. Lancet Oncol 2015;16:270–78 doi:1016/S1470-2045(15)70057-4 pmid:26065612

   CrossRefPubMed
4. 4.↵
   2. Vogelbaum MA,
   3. Jost S,
   4. Aghi MK, et al

   . Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) working group. Neurosurgery 2012;70:234–43 doi:10.1227/NEU.0b013e318223f5a7 pmid:21593697

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Abrey LE,
   3. Batchelor TT,
   4. Ferreri AJ, et al

   . International Primary CNS Lymphoma Collaborative Group. Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J Clin Oncol 2005;23:5034–43 doi:10.1200/JCO.2005.13.524 pmid:15955902

   Abstract/FREE Full Text
6. 6.↵
   2. Eisenhauer EA,
   3. Therasse P,
   4. Bogaerts J, et al

   . New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228–47 doi:10.1016/j.ejca.2008.10.026 pmid:19097774

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Macdonald DR,
   3. Cascino TL,
   4. Schold SC, et al

   . Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 1990;8:1277–80 doi:10.1200/JCO.1990.8.7.1277 pmid:2358840

   Abstract
8. 8.↵
   2. Galanis E,
   3. Buckner JC,
   4. Maurer MJ, et al

   . Validation of neuroradiologic response assessment in gliomas: measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods. Neuro Oncol 2006;8:156–65 doi:10.1215/15228517-2005-005 pmid:16533757

   CrossRefPubMed
9. 9.↵
   2. Chiavazza C,
   3. Pellerino A,
   4. Ferrio F, et al

   . Primary CNS lymphomas: challenges in diagnosis and monitoring. Biomed Res Int 2018;2018:3606970 doi:10.1155/2018/3606970 pmid:30035121

   CrossRefPubMed
10. 10.↵
    2. Grommes C,
    3. Rubenstein JL,
    4. DeAngelis LM, et al

    . Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma. Neuro Oncol 2019;21:296–305 doi:10.1093/neuonc/noy192 pmid:30418592

    CrossRefPubMed
11. 11.↵
    2. Vendrell JF,
    3. Frandon J,
    4. Boussat B, et al

    . Double reading of outsourced CT/MR radiology reports: retrospective analysis. J Patient Saf 2018 Aug 13. [Epub ahead of print] doi:10.1097/PTS.0000000000000525 pmid:30531236

    CrossRefPubMed
12. 12.↵
    2. Therasse P,
    3. Arbuck SG,
    4. Eisenhauer EA, et al

    . New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000;92:205–16 doi:10.1093/jnci/92.3.205 pmid:10655437

    CrossRefPubMedWeb of Science
13. 13.↵
    2. Shah GD,
    3. Kesari S,
    4. Xu R, et al

    . Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas. Neuro Oncol 2006;8:38–46 doi:10.1215/S1522851705000529 pmid:16443946

    CrossRefPubMed
14. 14.↵
    2. Hopper KD,
    3. Kasales CJ,
    4. Van Slyke MA, et al

    . Analysis of interobserver and intraobserver variability in CT tumor measurements. AJR Am J Roentgenol 1996;167:851–54 doi:10.2214/ajr.167.4.8819370 pmid:8819370

    CrossRefPubMedWeb of Science
15. 15.↵
    2. McErlean A,
    3. Panicek DM,
    4. Zabor EC, et al

    . Intra- and interobserver variability in CT measurements in oncology. Radiology 2013;269:451–59 doi:10.1148/radiol.13122665 pmid:23824993

    CrossRefPubMed
16. 16.
    2. Chappell R,
    3. Miranpuri SS,
    4. Mehta MP

    . Dimension in defining tumor response. J Clin Oncol 1998;16:1234 doi:10.1200/JCO.1998.16.3.1234 pmid:9508213

    CrossRefPubMed